Help Your Company Know What It Knows Part 2

In this episode, I guide you through our continued journey into the challenges around handling summary statistics. Building on our previous discussions, today we dive into the transformative solutions that extend beyond just the CDISC standards.

Help Your Company Know What It Knows Part 1

Today, I’m going to take you on a journey, a journey where we unravel the complexities of transforming the way companies handle their statistical results. So, listen in, because we’re about to explore solutions that go beyond the surface-level issues.

Cross-Over Studies: When Do They Offer a Great Advantage?

Cross-Over Studies: When Do They Offer a Great Advantage?

A crossover study is a longitudinal study where subjects receive multiple treatments in a sequence. This design allows subjects to serve as their own controls, enhancing the ability to address confounding factors. Crossover studies are particularly valuable in scenarios where treatments need to be compared, and their effects measured over multiple periods.

Risk Mitigation for Statisticians

Cross-Over Studies: When Do They Offer a Great Advantage?

In today’s episode, I discuss the crucial topic of risk management in clinical trials with guest Jess Thompson. Jess, the founder of the Association of Clinical Research Project Managers, shares her extensive experience in the field, emphasizing the importance of proactive risk identification and collaborative communication within project teams.